Clinical trial NCT00999063: Prevalence of Gastroesophageal Reflux Disease (GERD) in Patients With Upper Gastrointestinal Track (GIT) Symptoms in Thailand
Official title: Prevalence of GERD in Patients With upperGITsymptoms in Thailand
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Upper GIT Symptoms
Keywords: GerdQ
Lead sponsor: AstraZeneca
Sponsor class: INDUSTRY
First posted: 2009-10-21
Enrollment: 4108
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Time perspective: PROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: Primary care clinic

Brief summary: This is a prospective , epidemiological, multi-centre, phase IV study, approximately 5,000 patients who suffer with upper gastrointestinal tract symptoms. Each patient will be assessed for GERD with GerdQ Thai Version.


Eligibility criteria: Inclusion Criteria:

* Provision of informed consent prior to any study specific procedures
* Female or male aged at least 18 years
* Patient must be having symptoms suggestive of upper gastrointestinal tract symptoms such as heart burn/ regurgitation

Exclusion Criteria:

* Involvement in the planning and /or conduct of the study (applies to both AstraZeneca staff and /or staff at study site
* Participation in a clinical study(excluding non-interventional study or registry) during the last 3 months

Primary outcomes:
measure: Prevalence of gastroesophageal reflux disease (GERD) in patients presented with upper gastrointestinal tract symptoms
Secondary outcomes:
measure: Response to various treatments for patients who have been diagnosed of GERD
Other outcomes:
Locations:
city: Bangkok Noi
country: Thailand
facility: Research Site
state: Bangkok
city: Muang
country: Thailand
facility: Research Site
state: Bangkok
city: Pathumwan
country: Thailand
facility: Research Site
state: Bangkok
city: Rajthevee
country: Thailand
facility: Research Site
state: Bangkok
city: Ratchthewi
country: Thailand
facility: Research Site
state: Bangkok
city: Maerim
country: Thailand
facility: Research Site
state: Chiang Mai
city: Maung
country: Thailand
facility: Research Site
state: Chiang Mai
city: Maung
country: Thailand
facility: Research Site
state: Khon Kaen
city: Maung
country: Thailand
facility: Research Site
state: Nakhon Sri Thammarat
city: Maung
country: Thailand
facility: Research Site
state: Nakhonratchasima
city: Maung
country: Thailand
facility: Research Site
state: Nakhonsawan
city: Maung
country: Thailand
facility: Research Site
state: Nakornpathom
city: Muang
country: Thailand
facility: Research Site
state: Nonthaburi
city: Klong Luang
country: Thailand
facility: Research Site
state: Pathumthani
city: Maung
country: Thailand
facility: Research Site
state: Phetchabun
city: Maung
country: Thailand
facility: Research Site
state: Phuket
city: Maung
country: Thailand
facility: Research Site
state: Rajburi
city: Maung
country: Thailand
facility: Research Site
state: Roiet
city: Maung
country: Thailand
facility: Research Site
state: Samut sakorn
city: Maung
country: Thailand
facility: Research Site
state: Sukhothai
city: Maung
country: Thailand
facility: Research Site
state: Trang
city: Maung
country: Thailand
facility: Research Site
state: Ubonratchathani
city: Varin Chamrap
country: Thailand
facility: Research Site
state: Ubonratchathani
city: Muang
country: Thailand
facility: Research Site
state: Udon Thani
city: Maung
country: Thailand
facility: Research Site
state: Uttaradit
Study officials:
affiliation: Siriraj Hospital
name: Somchai Leelasukolvong, Dr.
role: PRINCIPAL_INVESTIGATOR
References: